Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning - Certain Manila clams may be unsafe due to a marine biotoxin which causes Paralytic Shellfish Poisoning


Product photo is available: https://www.inspection.gc.ca/eng/1600812242248/1600812248453

OTTAWA, ON, Sept. 22, 2020 /CNW/ - Evergreen International Foodstuffs Ltd. is recalling certain Manila clams from the marketplace due to a marine biotoxin which causes Paralytic Shellfish Poisoning. Consumers should not consume the recalled product described below.

These Manila clams may also have been sold in bulk or in smaller packages with or without a label and may not bear the same brand, product name, or code as described below.

The following product has been sold in British Columbia, and Ontario.

Recalled product

Brand

Product

Size

Code

Evergreen Int'l Foodstuffs Ltd.

Manila clams

25 lb.

Harvest Date: Sep 16, 2020

Processing Date: Sep 17, 2020

Harvest Location: B.C. 17-20

Lot# 21057

What you should do

Check to see if you have the recalled product in your home. Recalled products should be thrown out or returned to the store where they were purchased. If you are unsure of the source of the clams, check with your place of purchase.

Paralytic shellfish toxins are a group of natural toxins that sometimes accumulate in bivalve shellfish that include oysters, clams, scallops, mussels and cockles. Non-bivalve shellfish, such as whelks, can also accumulate Paralytic Shellfish Poisoning (PSP) toxins. These toxins can cause Paralytic Shellfish Poisoning (PSP) if consumed. Symptoms of Paralytic Shellfish Poisoning (PSP) include tingling and numbness of the lips, tongue, hands and feet, and difficulty swallowing with an onset of a few minutes and up to 10 hours after consumption. In severe situations, this can proceed to difficulty walking, muscle paralysis, respiratory paralysis and death.

Background

This recall was triggered by Canadian Food Inspection Agency (CFIA) test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled product from the marketplace.

Illnesses

There have been no reported illnesses associated with the consumption of this product.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 07:32
Duchesnay Pharmaceutical Group (DPG), one of the eight companies across the country chosen to participate in the Government of Canada's Global Hypergrowth Project, is very proud to announce that it has been awarded the Parity Certificationtm by Women...

at 06:30
The global microscopy market is poised for significant growth, expected to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, growing at a CAGR of 5.4%. Key drivers include rising cases of chronic diseases necessitating effective...

at 06:25
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...



News published on and distributed by: